Compare BTTC & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTTC | BFRG |
|---|---|---|
| Founded | 1990 | 2017 |
| Country | Malaysia | United States |
| Employees | N/A | 17 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 6.9M |
| IPO Year | N/A | N/A |
| Metric | BTTC | BFRG |
|---|---|---|
| Price | $0.78 | $0.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 138.8K | ★ 253.4K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $0.43 |
| 52 Week High | $11.22 | $2.04 |
| Indicator | BTTC | BFRG |
|---|---|---|
| Relative Strength Index (RSI) | 36.12 | 47.22 |
| Support Level | $0.68 | $0.65 |
| Resistance Level | $1.23 | $0.71 |
| Average True Range (ATR) | 0.11 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 16.29 | 62.24 |
Black Titan Corp provides human resource and payroll consulting, software implementation, and training solutions using PeopleSoft platforms. The company's revenue is mainly derived from the provision of HCM solutions, followed by the provision of IT staff augmentation, outsourcing and consulting services.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.